Suzetrigine for urinary incontinence, stress

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 May 2026: Trial registered, NCT07600697

The trials

NCT07600697: Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery

State
Not started
Phase
Phase 4
People
120 planned
Started
1 Nov 2026
Primary completion
1 Jul 2027
Arms
Suzetrigine-Based Regimen
Results
None posted
  1. 22 May 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Journavx, Suz, Suzetrigine (Journavx), Suzetrigine (SUZ), Suzetrigine Group, oral suzetrigine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.